Pulmonary Hypertension: A Cancerous Proliferative Vascular Disorder?

All credit to Prof. Serge Adnot, Professor of Physiology at INSERM, Creteil, France

Part 3

Additional key-words: malignancy,clinical trials,serotonin

About the author

Henri Mondor Hospital

France

Henri Mondor Hospital

France

Authors: Kuo FY, Huang WC, Tang PL, Cheng CC, Chiang CH, Lin HC, Chuang TJ, Wann SR, Mar GY, Liu CP, Cheng JT, Wu MC Source: Postgrad Med J

Authors: Liu Y, Dai C, Zhou Y, Qiao J, Tang B, Yu W, Zhang R, Liu Y, Lu SE Source: Appl Environ Microbiol

Authors: Palmero A, Alcala G, Alvarez R Source: Nanomaterials (Basel)

Authors: Moussa O, Ardissino M, Muttoni S, Faraj A, Tang A, Khan O, Collins P, Jaffer U, Purkayastha S Source: Langenbecks Arch Surg

Authors: Szparaga Ł, Bartosik P, Gilewicz A, Mydłowska K, Ratajski J Source: Materials (Basel)

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI